Study | All pts | TS detection method | Chemotherapy regimen | Ethnicity | TS expression | Evaluable for response | Disease stage | ECOGPS | TS high/+ | TS low/- | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  |  |  |  | OR (pts) | Total pts | OR (pts) | Total pts |
Bepler et al. [6] | 52 | RT-PCR | pemetrexed + gemcitabine | Caucasian | 35 | 35 | I-III | NR | 5 | 17 | 7 | 18 |
Chang et al. [30] | 110 | IHC | pemetrexed | Asian | 55 | 52 | advanced or reoccurent | 0-4 | 23 | 41 | 4 | 11 |
Chen et al. [21] | 268 | IHC | pemetrexed | Asian | 49 | 42 | IIIB-IV | NR | 3 | 20 | 5 | 22 |
Park et.al [22] | 98 | IHC | pemetrexed | Asian | 98 | 88 | IB,IIIA-IV | NR | 5 | 54 | 5 | 34 |
Takezawa et al. [18] | 24 | IHC | pemetrexed + platinum | Asian | 24 | 24 | IIIB-IV | 0-1 | 1 | 12 | 6 | 12 |
Wang et al. [19] | 38 | RT-PCR | pemetrexed + platinum | Asian | 38 | 38 | IIIB-IV | 0-1 | 2 | 10 | 11 | 28 |
Igawa et al. [31] | 104 | IHC | pemetrexed | Asian | 54 | 54 | IIIB-IV or reoccurent | 0-3 | 0 | 23 | 5 | 31 |
Sun et al. [17] | 285 | IHC | pemetrexed | Asian | 149 | 149 | IIIB-IV | 0-1 | 9 | 75 | 21 | 74 |
 |  |  | pemetrexed + platinum | Asian | 44 | 44 | IIIB-IV | 0-1 | 4 | 17 | 13 | 27 |